Elevance Health

When researching Elevance Health, analysts typically begin with its Health Care sector positioning and Managed Health Care industry dynamics. Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

The company reports trailing twelve-month revenue of $50.18B and net income of $1.76B. Key metrics include a return on equity of 4.0%, a debt-to-equity ratio of 1.86.

FINOTAUR provides free research summaries, news aggregation, and fundamentals for ELV to support both active traders and long-term investors.